The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

Getting your yearly flu vaccine is essential to prevent illness during cold and flu season. But if you’re not a fan of needles, the experience isn’t exactly enjoyable. Enter: FluMist, the newly FDA-approved at-home nasal flu vaccine.

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be able to administer themselves

The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.

Gaithersburg, Maryland-based MedImmune has received the FDA’s approval of its FluMist nasal spray flu vaccine, meaning no physician needed.

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist contains a weakened form of live influenza virus strains and is sprayed in the nose. A prescription is still required.

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered flu vaccine option.

The wait for a flu shot at your doctor's office or pharmacy may soon be a thing of the past. The U.S. Food and Drug Administration has approved FluMist nasal spray as the first influenza vaccine for self-administration at home.

The Food and Drug Administration (FDA) has approved the first-ever influenza vaccine that can be administered at home. It’s a nasal spray vaccine called FluMist, and it’s been